维普中文期刊产品整合服务
575篇 您的检索式:作者名="TABAK"
    题名 作者 年代 出处 被引量
1肥胖和动脉老化:Whitehall Ⅱ队列主动脉僵硬度纵向研究显示文摘该研究旨在确定肥胖症是否中年后动脉硬化加速的独立预测因子。纳入Whitehall Ⅱ研究受试者男性3789例,女性1383例,平均年龄66岁,均接受颈-股动脉压检测,4年后再次进行测定。一般肥胖状况由体质量指数,中心肥胖由腰围和腰臀比,脂肪含量百分比由身体阻抗来评估。通过线性混合模型,对年龄、性别、种族和平均动脉压进行调整后,所有肥胖症测量指标与主动脉硬化[通过随访的脉搏波传导速度(pulse wave velocity,PWV)较基线增加值来确定]相关。刘莉 叶鹏 Brunner EJ Shipley MJ Ahmadi-Abhari S Tabak AG McEniery CM Wilkinson IB Marmot MG Singh-Manoux A Kivimaki M 2015中华高血压杂志2015,23,6:8
2A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding显示文摘John R. Saltzman Ying P. Tabak Brian H. Hyett Xiaowu Sun Anne C. Travis Richard S. Johannes 2011Gastrointestinal Endoscopy2011,,6:3
3Endoscopic retrograde cholangiopancreatography in elderly patients: Difficult cannulation and adverse events显示文摘BACKGROUND Endoscopic retrograde cholangiopancreatography(ERCP)is a valuable therapeutic technique for pancreatobiliary diseases,and its application in the elderly is no longer limited.However,a higher incidence of procedure difficulty and periprocedural adverse events might be expected in elderly patients due to the presence of other medical disorders and the poor general condition of this population.AIM To evaluate the incidence,causes,and management of difficult biliary cannulation during ERCP in elderly patients and the role of difficult cannulation as a risk factor for adverse events.METHODS A total of 614 patients who underwent ERCP during the study period were prospectively studied and divided into two groups based on their age.One hundred and forty-six patients were aged 80 years or older and 468 patients were aged less than 80 years.The primary outcome measurements were cannulation difficulty,cannulation success rate,ERCP procedure time,and related adverse events.RESULTS There was no difference in the incidence of difficult cannulation among the two groups(32.9%vs 34.4%,P=0.765),as well as in the cannulation success rate(96.6%vs 96.8%,P=0.54).The cannulation techniques were shown to be safe and efficient in achieving successful cannulation.Logistic regression analysis showed that patients aged 80 years or older were not associated with increased adverse events;however,difficult cannulation cases[adjusted odds ratio(AOR)=3.478;95%confidence interval(CI):1.877-6.442;P<0.001]and patients with Charlson Comorbidity Index≥2(AOR=1.824;95%CI:0.993-3.349;P=0.045)were more likely to develop adverse events.In contrast,other factors including age≤65(AOR=3.460;95%CI:1.511-7.922;P=0.003),female gender(AOR=2.362;95%CI=1.089-5.124;P=0.030),difficult cannulation(AOR=4.527;95%CI:2.078-9.860;P<0.001),and patients with cholangitis(AOR=3.261;95%CI:1.204-8.832;P=0.020)were strongly associated with a higher rate of post-ERCP pancreatitis.CONCLUSION Advanced age has not been proved to be a risk factor for difficult cannulation,and secondary cannulation techniques can be safely and efficaciously utilized in this group.Patients with a Charlson Comorbidity Index≥2 and difficult cannulation are associated with an increased overall adverse events rate,while age≥80 years is not.Fatema Tabak Hui-Shan Wang Quan-Peng Li Xian-Xiu Ge Fei Wang Guo-Zhong Ji Lin Miao 2020World Journal of Clinical Cases2020,8,14:2
4Formation of strong fronts in the 2-D quasi-geostrophic thermal active scalar显示文摘Constantin P Majda A Tabak E 1994Nonlinearity1994,7,6:1
5Using an objective structured clinical examination (OSCE) to assess multiple physician competencies in postgraduate training 显示文摘Jefferies A Simmons B Tabak D 2007Mcd Teach2007,29,23:1
6Advances in biotreatment of acid mine drainage and biorecovery of metals: metal precipitation for recovery and recycle 显示文摘Tabak HH Scharp R Burckle J 2003Biodegradation2003,14,6:1
7Absorption of ultra-intense laser pulses显示文摘Wilks S C Kruer W L Tabak M 1992Phys Rev Lett1992,69,9:1
8The use of physical restraints for patients suffering from dementia显示文摘Weiner C Tabak N Bergman R 2003Nurs Ethics2003,10,5:1
9Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitisB using HBsAg and HBV DNA levels 显示文摘Rijckborst V Hansen BE Cakaloglu Y Ferenci P Tabak F Akdogan M Simon K Akarca US Flisiak R Verhey E Van Vuuren AJ Boucher CA ter Borg MJ Janssen HL 2010Hepatology2010,52,2:1
10Prolonged elimination half- life of phenol after dermal exposure显示文摘Bentur Y Shoshani O Tabak A 1998J Clin Toxicol1998,36,:1
11Ignition and high gain with ultrapowerful lasers显示文摘Tabak M Hammer J Glinsky M E 1994Phys Plasmas1994,1,5:1
12Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants显示文摘GELAMO E L TABAK M 2000Spectrochimica Acta Part A2000,56,:1
13Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of cuhure-positive pneumonia 显示文摘Kollef M H Shorr A Tabak Y P 2005Chest2005,128,6:1
14Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b显示文摘Erik H.C.J. Buster Hajo J. Flink Yilmaz Cakaloglu Krzysztof Simon J?rg Trojan Fehmi Tabak Thomas M.K. So S. Victor Feinman Tomasz Mach Ulus S. Akarca Martin Schutten Wanda Tielemans Anneke J. van Vuuren Bettina E. Hansen Harry L.A. Janssen 2008Gastroenterology2008,,2:1
15Correlation of Quantitative Assay of HBsAg and HBV DNA Levels During Chronic HBV Treatment显示文摘Ozaras R Tabak F Tahan V 2008Dig DisSci2008,53,11:1
16Fever of unknown origin: a review of 20 patients with adult-onset Still's disease 显示文摘Mert A Ozaras R Tabak F 2003Clin Rheumatol2003,22,2:1
17Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with i- onic surfactants 显示文摘Gelamo E L Tabak M 2000Spectrochimica Acta Part A2000,56,:1
18High yield inertial confinement fusion target design for a Z-pinch-driven hohlraum显示文摘Hammer J H Tabak M Wilks S C 1999Physicsof Plasmas1999,6,5:1
19Ornidazole-induced liver damage:report of three cases and review of the literature显示文摘Tabak F Ozaras R Erzin Y 0,,05:1
20Ignition and high gain with ultrapowerful lasers显示文摘Tabak M Hammer J Glinsky M E 1994Phys Plasmas1994,1,5:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费